Vistin Pharma - AGM Information 2018

Vistin Pharma ASA : Energy trading business to commence operations

Oslo, Norway, 8 May 2018

Reference is made to the announcements from Vistin Pharma ASA on 16 March and

22 March regarding the development of a new business area within energy trading.

At the annual general meeting held today the shareholders approved the required

changes to the articles of association. The shareholders also approved the

private placement of NOK 300 million in gross proceeds completed on 22 March, to

fund the establishment of the energy trading business and trading activities

within this area. Part of Vistin Pharma's strategy is to invest in asymmetrical

investment opportunities caused by fundamental changes in the oil space, and the

Company is now in a position to commence its trading activities. Vistin Pharma

plans to invest in energy related financial instruments in the near future,

which is expected to create a significant financial exposure. The total

financial exposure of these investments will not exceed the capital raised to

fund the energy trading activity. All trading activities will be carried out

through the wholly owned subsidiary Vistin Trading AS.

For further information, please contact:

Kjell-Erik Nordby

CEO

+47 91 36 42 80

Gunnar Manum

CFO

+47 95 17 91 90

This information is subject to the disclosure requirements pursuant to section

5-12 of the Norwegian Securities Trading Act.

AI assistant